nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—ABCB1—adrenal gland cancer	0.933	1	CbGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000201	0.003	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000197	0.00295	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000197	0.00295	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—TSHR—adrenal gland cancer	0.000194	0.0029	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000191	0.00286	CbGpPWpGaD
Sumatriptan—MAOA—Biological oxidations—POMC—adrenal gland cancer	0.00019	0.00283	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000187	0.00279	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.000186	0.00279	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—SDHB—adrenal gland cancer	0.000183	0.00273	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00018	0.0027	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00017	0.00255	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—SDHB—adrenal gland cancer	0.000169	0.00253	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000169	0.00252	CbGpPWpGaD
Sumatriptan—HTR1D—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000168	0.00252	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000168	0.00251	CbGpPWpGaD
Sumatriptan—MAOA—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000166	0.00248	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000165	0.00247	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000165	0.00246	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000164	0.00245	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.000164	0.00245	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000162	0.00242	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—POMC—adrenal gland cancer	0.000159	0.00238	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—SDHB—adrenal gland cancer	0.000156	0.00234	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—GNAS—adrenal gland cancer	0.000151	0.00226	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00015	0.00224	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00015	0.00224	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—GNAS—adrenal gland cancer	0.000148	0.00222	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—GNRHR—adrenal gland cancer	0.000148	0.00221	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000147	0.0022	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000147	0.00219	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000146	0.00219	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—SDHB—adrenal gland cancer	0.000145	0.00217	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—GNRHR—adrenal gland cancer	0.000145	0.00216	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000144	0.00215	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000144	0.00215	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00014	0.00209	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—GNRH1—adrenal gland cancer	0.000138	0.00207	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000137	0.00205	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000137	0.00205	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000134	0.00201	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000134	0.002	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000134	0.002	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—TSHR—adrenal gland cancer	0.000134	0.002	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000131	0.00196	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—TSHR—adrenal gland cancer	0.000131	0.00195	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000129	0.00193	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—BRAF—adrenal gland cancer	0.000127	0.0019	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—CDC42—adrenal gland cancer	0.000127	0.0019	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SPRY2—adrenal gland cancer	0.000127	0.00189	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000126	0.00189	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000126	0.00188	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000124	0.00186	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TSHR—adrenal gland cancer	0.000123	0.00184	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000123	0.00184	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000123	0.00184	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—GNAS—adrenal gland cancer	0.000121	0.00182	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—SDHD—adrenal gland cancer	0.000118	0.00176	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—RRM1—adrenal gland cancer	0.000118	0.00176	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000117	0.00175	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MEN1—adrenal gland cancer	0.000116	0.00173	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.000113	0.00169	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000112	0.00167	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000111	0.00166	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00011	0.00165	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00011	0.00165	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00011	0.00164	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—RRM1—adrenal gland cancer	0.000109	0.00163	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—SDHD—adrenal gland cancer	0.000109	0.00163	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000109	0.00163	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000108	0.00162	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000108	0.00162	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000102	0.00153	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—POMC—adrenal gland cancer	0.000102	0.00152	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—SDHD—adrenal gland cancer	0.000101	0.00151	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—RRM1—adrenal gland cancer	0.000101	0.00151	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	9.98e-05	0.00149	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—POMC—adrenal gland cancer	9.98e-05	0.00149	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—TSHR—adrenal gland cancer	9.96e-05	0.00149	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—GNAS—adrenal gland cancer	9.91e-05	0.00148	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—GNRH1—adrenal gland cancer	9.81e-05	0.00147	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GNRHR—adrenal gland cancer	9.67e-05	0.00145	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ZNRF3—adrenal gland cancer	9.63e-05	0.00144	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—TSHR—adrenal gland cancer	9.63e-05	0.00144	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PRKACA—adrenal gland cancer	9.58e-05	0.00143	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	9.49e-05	0.00142	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PRKACA—adrenal gland cancer	9.38e-05	0.0014	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—RRM1—adrenal gland cancer	9.33e-05	0.0014	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—SDHD—adrenal gland cancer	9.33e-05	0.0014	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	9.31e-05	0.00139	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—POMC—adrenal gland cancer	9.01e-05	0.00135	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SH3KBP1—adrenal gland cancer	8.99e-05	0.00134	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—CDC42—adrenal gland cancer	8.95e-05	0.00134	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PRKACA—adrenal gland cancer	8.85e-05	0.00132	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—GNRH1—adrenal gland cancer	8.85e-05	0.00132	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—MED12—adrenal gland cancer	8.79e-05	0.00131	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	8.78e-05	0.00131	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CDC42—adrenal gland cancer	8.76e-05	0.00131	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	8.76e-05	0.00131	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—TSHR—adrenal gland cancer	8.74e-05	0.00131	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	8.74e-05	0.00131	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—GNRH1—adrenal gland cancer	8.67e-05	0.0013	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	8.62e-05	0.00129	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—GNAS—adrenal gland cancer	8.55e-05	0.00128	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ZNRF3—adrenal gland cancer	8.46e-05	0.00126	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—GNAS—adrenal gland cancer	8.37e-05	0.00125	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—POMC—adrenal gland cancer	8.18e-05	0.00122	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—MED12—adrenal gland cancer	8.14e-05	0.00122	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CDC42—adrenal gland cancer	8.13e-05	0.00122	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SPRY2—adrenal gland cancer	8.09e-05	0.00121	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CDC42—adrenal gland cancer	7.96e-05	0.00119	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SPRY2—adrenal gland cancer	7.93e-05	0.00118	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TSHR—adrenal gland cancer	7.89e-05	0.00118	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	7.86e-05	0.00117	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SDHB—adrenal gland cancer	7.83e-05	0.00117	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—GNAS—adrenal gland cancer	7.77e-05	0.00116	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TSHR—adrenal gland cancer	7.72e-05	0.00115	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—GNAS—adrenal gland cancer	7.61e-05	0.00114	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—POMC—adrenal gland cancer	7.6e-05	0.00114	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—MED12—adrenal gland cancer	7.52e-05	0.00112	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CDC42—adrenal gland cancer	7.51e-05	0.00112	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MEN1—adrenal gland cancer	7.42e-05	0.00111	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MEN1—adrenal gland cancer	7.26e-05	0.00109	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IGF2—adrenal gland cancer	7.24e-05	0.00108	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—GNAS—adrenal gland cancer	7.17e-05	0.00107	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PRKACA—adrenal gland cancer	7.15e-05	0.00107	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IGF1R—adrenal gland cancer	7e-05	0.00105	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—MED12—adrenal gland cancer	6.96e-05	0.00104	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	6.72e-05	0.001	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CDC42—adrenal gland cancer	6.68e-05	0.000998	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—POMC—adrenal gland cancer	6.67e-05	0.000998	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GNRH1—adrenal gland cancer	6.6e-05	0.000987	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	6.42e-05	0.00096	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PRKACA—adrenal gland cancer	6.41e-05	0.000959	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—GNAS—adrenal gland cancer	6.38e-05	0.000954	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	6.28e-05	0.000938	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.27e-05	0.000937	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CDC42—adrenal gland cancer	6.06e-05	0.000906	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SPRY2—adrenal gland cancer	6.04e-05	0.000903	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TERT—adrenal gland cancer	6.02e-05	0.000901	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PRKACA—adrenal gland cancer	5.94e-05	0.000888	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	5.93e-05	0.000887	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TSHR—adrenal gland cancer	5.88e-05	0.00088	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	5.86e-05	0.000876	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	5.86e-05	0.000876	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	5.8e-05	0.000867	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—GNAS—adrenal gland cancer	5.79e-05	0.000866	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—POMC—adrenal gland cancer	5.76e-05	0.000861	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	5.75e-05	0.000859	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PRKACA—adrenal gland cancer	5.66e-05	0.000846	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—POMC—adrenal gland cancer	5.64e-05	0.000843	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	5.6e-05	0.000837	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PRKACA—adrenal gland cancer	5.54e-05	0.000829	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MEN1—adrenal gland cancer	5.53e-05	0.000827	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PRKACA—adrenal gland cancer	5.48e-05	0.00082	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	5.36e-05	0.000801	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	5.32e-05	0.000796	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	5.3e-05	0.000793	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—BAD—adrenal gland cancer	5.24e-05	0.000783	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—POMC—adrenal gland cancer	5.23e-05	0.000782	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GNAS—adrenal gland cancer	5.2e-05	0.000777	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	5.17e-05	0.000772	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—POMC—adrenal gland cancer	5.12e-05	0.000766	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ABCB1—adrenal gland cancer	5.1e-05	0.000762	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	5.09e-05	0.00076	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PRKACA—adrenal gland cancer	5.08e-05	0.000759	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SDHD—adrenal gland cancer	5.05e-05	0.000754	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—RRM1—adrenal gland cancer	5.05e-05	0.000754	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	4.86e-05	0.000726	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—POMC—adrenal gland cancer	4.83e-05	0.000722	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GNAS—adrenal gland cancer	4.81e-05	0.00072	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDC42—adrenal gland cancer	4.8e-05	0.000718	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—BRAF—adrenal gland cancer	4.77e-05	0.000713	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	4.75e-05	0.00071	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ABCB1—adrenal gland cancer	4.72e-05	0.000706	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDC42—adrenal gland cancer	4.7e-05	0.000703	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF2—adrenal gland cancer	4.63e-05	0.000692	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—EGFR—adrenal gland cancer	4.62e-05	0.000691	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—GNAS—adrenal gland cancer	4.59e-05	0.000686	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	4.55e-05	0.000681	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF2—adrenal gland cancer	4.53e-05	0.000678	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—GNAS—adrenal gland cancer	4.49e-05	0.000672	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF1R—adrenal gland cancer	4.47e-05	0.000669	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GNAS—adrenal gland cancer	4.44e-05	0.000664	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF1R—adrenal gland cancer	4.38e-05	0.000655	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ABCB1—adrenal gland cancer	4.36e-05	0.000652	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—POMC—adrenal gland cancer	4.3e-05	0.000642	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PRKACA—adrenal gland cancer	4.22e-05	0.000631	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GNAS—adrenal gland cancer	4.11e-05	0.000615	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ABCB1—adrenal gland cancer	4.04e-05	0.000604	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	3.9e-05	0.000583	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TERT—adrenal gland cancer	3.85e-05	0.000576	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.82e-05	0.000572	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TERT—adrenal gland cancer	3.77e-05	0.000564	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	3.77e-05	0.000564	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MED12—adrenal gland cancer	3.76e-05	0.000562	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	3.71e-05	0.000554	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	3.58e-05	0.000535	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—POMC—adrenal gland cancer	3.5e-05	0.000523	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	3.45e-05	0.000516	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CTNNB1—adrenal gland cancer	3.45e-05	0.000515	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	3.42e-05	0.000512	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	3.42e-05	0.000512	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—BAD—adrenal gland cancer	3.35e-05	0.000501	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	3.34e-05	0.000499	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	3.28e-05	0.000491	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—POMC—adrenal gland cancer	3.24e-05	0.000485	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	3.14e-05	0.00047	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—POMC—adrenal gland cancer	3.09e-05	0.000462	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—BRAF—adrenal gland cancer	3.05e-05	0.000456	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	3.03e-05	0.000453	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	3.02e-05	0.000452	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	3e-05	0.000449	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—POMC—adrenal gland cancer	2.99e-05	0.000447	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	2.99e-05	0.000447	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—EGFR—adrenal gland cancer	2.96e-05	0.000442	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	2.93e-05	0.000438	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	2.9e-05	0.000433	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	2.87e-05	0.00043	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—adrenal gland cancer	2.79e-05	0.000417	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—POMC—adrenal gland cancer	2.77e-05	0.000414	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.74e-05	0.00041	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EGFR—adrenal gland cancer	2.73e-05	0.000408	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—adrenal gland cancer	2.59e-05	0.000387	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TERT—adrenal gland cancer	2.52e-05	0.000377	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	2.5e-05	0.000374	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—adrenal gland cancer	2.39e-05	0.000357	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	2.3e-05	0.000345	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TP53—adrenal gland cancer	2.29e-05	0.000343	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	2.28e-05	0.00034	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.22e-05	0.000333	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—adrenal gland cancer	2.21e-05	0.00033	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	2.21e-05	0.00033	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CTNNB1—adrenal gland cancer	2.2e-05	0.00033	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BAD—adrenal gland cancer	2.19e-05	0.000328	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	2.16e-05	0.000323	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—POMC—adrenal gland cancer	2.02e-05	0.000302	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	2e-05	0.000299	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	1.94e-05	0.00029	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EGFR—adrenal gland cancer	1.75e-05	0.000261	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	1.71e-05	0.000256	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.64e-05	0.000246	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—POMC—adrenal gland cancer	1.5e-05	0.000224	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TP53—adrenal gland cancer	1.47e-05	0.000219	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.44e-05	0.000216	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	1.44e-05	0.000215	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	1.3e-05	0.000195	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.19e-05	0.000179	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	1.14e-05	0.000171	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	1.09e-05	0.000164	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TP53—adrenal gland cancer	9.6e-06	0.000144	CbGpPWpGaD
